Go to:
Logótipo
Você está em: Start > Publications > View > Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview
Map of Premises
Principal
Publication

Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview

Title
Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview
Type
Another Publication in an International Scientific Journal
Year
2014
Authors
Antunes Lopes, T
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Cruz C.D.
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Francisco Cruz
(Author)
FMUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Sievert, KD
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 24
Pages: 352-357
ISSN: 0963-0643
Other information
Authenticus ID: P-009-HN8
Abstract (EN): Purpose of review Biomarkers constitute objectively measurable characteristics that can be evaluated as indicators of physiological and pathogenic processes and might be used as diagnostic, prognostic or predictive tools in clinical care. This review examines the availability of biomarkers to treat the dynamic and complex symptoms of overactive bladder (OAB). Recent findings OAB biomarkers may contribute to reveal the origin of storage symptoms in otherwise healthy individuals. The research encompassing the changes that occur in the bladder or in the peripheral (and central) nervous system might be determined through blood or urinary molecules (neurotrophins, ATP, prostaglandins, C-reactive protein and cytokines) or the measurement of events occurring in the bladder wall (bladder wall or detrusor wall thickness, oxyhemoglobin and deoxyhemoglobin concentration). These biomarkers might contribute to a better understanding of the pathophysiologic mechanisms underlying OAB. Summary The word biomarker to name all the parameters described above, from bladder wall thickness to urinary molecules, has been introduced to call the attention to a field wherein objective noninvasive parameters were nonexistent. OAB treatment based on a biomarker, in comparison to the treatment based on a diagnosis made from a careful history and exclusion of urinary tract infection, is not supported by current literature.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 6
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

What is in the pipeline for new treatments for bladder pain syndrome/ interstitial cystitis? (2024)
Another Publication in an International Scientific Journal
Dias, D; Mendes, PA; Paulo Dinis; Pinto, RA
Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence (2009)
Another Publication in an International Scientific Journal
Andersson, KE; Chapple, CR; Cardozo, L; Francisco Cruz; Hashim, H; Michel, MC; Tannenbaum, C; Wein, AJ
Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it? (2009)
Another Publication in an International Scientific Journal
Carlos Silva; Francisco Cruz
Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard? (2014)
Another Publication in an International Scientific Journal
João Silva; Carlos Silva; Francisco Cruz
Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update (2004)
Another Publication in an International Scientific Journal
Francisco Cruz; Carlos Silva

See all (8)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Medicina Dentária da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-10 at 09:04:23 | Privacy Policy | Personal Data Protection Policy | Whistleblowing | Electronic Yellow Book